Viia Valge-Archer - Concepedia

Author

Viia Valge-Archer

Also Known As

V E Valge-Archer, V Valge-Archer, V. Valge-Archer, Viia E Valge-Archer, Viia E. Valge-Archer, Viia E. Valge-archer, Viia Valge-Archer

125

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Université Paris Cité AstraZeneca (United States)Sorbonne Université Dana-Farber Cancer Institute

About

Viia Valge-Archer is an author at AstraZeneca (United Kingdom) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.8K
2	Cell Biology	8	8	1.5K
3	Health Sciences	1	1	407
4	Natural Sciences	1	1	215
5	Allergy	1	1	37

Viia Valge-Archer

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell, Immunity Tumor BiologyMedicineImmunologyStronger PredictorPathology	2016	1K
Nuclear factor of activated T cells contains Fos and Jun Jugnu Jain, Patricia G. McCaffrey, Viia Valge-Archer, Nature Nuclear FactorSignal TransductionCell RegulationT-regulatory CellImmunology	1992	503
The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis Bernhard Mlecnik, Gabriela Bindea, Amos Kirilovsky, Science Translational Medicine	2016	469
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson, Cancer Immunology Research ImmunologyImmunoeditingImmunotherapeutic Drug DiscoveryImmunotherapeuticsImmunotherapy	2016	407
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, Cancer Cell Immune EvasionCancer ImmunosurveillanceMedicineImmunologyBiological Microenvironments	2018	278
Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses Frann Bennett, Deborah Luxenberg, Vincent Ling, The Journal of Immunology	2003	275
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival Bernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, JNCI Journal of the National Cancer Institute	2017	242
Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell, Science Translational Medicine	2014	224
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Viia Valge-Archer, H Osada, Alan J. Warren, Proceedings of the National Academy of Sciences Mixed-phenotype Acute LeukemiaGeneticsMolecular BiologyCellular PhysiologyT-cell Acute Leukemia	1994	215
Analysis of the AP-1 sites in the IL-2 promoter Jugnu Jain, Viia Valge-Archer, Anjana Rao The Journal of Immunology	1992	177

Page 1